Arindam Sarkar

Arindam Sarkar

Auto-generated profile, based on publicly available information

Arindam Sarkar

Akamara Therapeutics, Cambridge, MA, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2010 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
SPSushanta K. Pal
Sushanta K. Pal
PBPradip Bag
Pradip Bag
ASArindam Sarkar
Arindam Sarkar
XCXiaoliu Chi
Xiaoliu Chi
MIMikhail E. Itkis
Mikhail E. Itkis
RHRobert C. Haddon
Robert C. Haddon

18 September 2008 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
RHRobert C. Haddon
Robert C. Haddon
ASArindam Sarkar
Arindam Sarkar
SPSushanta K. Pal
Sushanta K. Pal
XCXiaoliu Chi
Xiaoliu Chi
MIMikhail E. Itkis
Mikhail E. Itkis
FTFook S. Tham
Fook S. Tham

4 November 2019 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
NGNimish Gupta
Nimish Gupta
AAAasif Ansari
Aasif Ansari
GDGaurao V. Dhoke
Gaurao V. Dhoke
MCMaheshwerreddy Chilamari
Maheshwerreddy Chilamari
JSJwala Sivaccumar
Jwala Sivaccumar
SSShiladitya Sengupta
Shiladitya Sengupta

9 December 2016 in Chemical Science
Verified
Journal Article
Open access
PDF file
NGNimish Gupta
Nimish Gupta
JKJohny Kancharla
Johny Kancharla
SKShelly Kaushik
Shelly Kaushik
AAAasif Ansari
Aasif Ansari
SHSamad Hossain
Samad Hossain
SSShiladitya Sengupta
Shiladitya Sengupta
Despite the advances in the design of antibody–drug conjugates (ADCs), the search is still ongoing for novel approaches that lead to increased stability and homogeneity of the ADCs. We report, for the first time, an ADC platform technology using a platinum(II)-based linker that can re-bridge the inter-chain cysteines in the antibody, post-reduction. The strong platinum–sulfur interaction improves the stability of the ADC when compared with a standard maleimide-linked ADC thereby reducing the linker–drug exchange with albumin significantly. Moreover, due to the precise conserved locations of cysteines, both homogeneity and site-specificity are simultaneously achieved. Additionally, we demonstrate that our ADCs exhibit increased anticancer efficacy in vitro and in vivo. The Pt-based ADCs can emerge as a simple and exciting proposition to address the limitations of the current ADC linker technologies.

4 May 2009 in Chemistry of Materials
Verified
Journal Article
Closed access
ASArindam Sarkar
Arindam Sarkar
SPSushanta K. Pal
Sushanta K. Pal
MIMikhail E. Itkis
Mikhail E. Itkis
PLPuhong Liao
Puhong Liao
FTFook S. Tham
Fook S. Tham
RHRobert C. Haddon
Robert C. Haddon

1 April 2015 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
AMAmritaa Mitra
Amritaa Mitra
APAnand Pariyar
Anand Pariyar
SBSuranjana Bose
Suranjana Bose
PBPinaki Bandyopadhyay
Pinaki Bandyopadhyay
ASArindam Sarkar
Arindam Sarkar